medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2020, Number 4

<< Back Next >>

Acta Med 2020; 18 (4)

Coronavirus disease 2019 (COVID-19) and pregnancy

Domínguez PR, Alva AN, Delgadillo MJJ, Enríquez LR, Flores PF, Portillo UEF, Chio MR

Language: Spanish
References: 37
Page: 399-406
PDF size: 185.83 Kb.


ABSTRACT

Coronavirus disease 2019 (COVID-19) is an emerging disease with a rapid increase in cases and deaths since its first identification in Wuhan, China, in December 2019. Amid a rapidly evolving outbreak that could have significant effects on our health and medical infrastructure, the particular needs of pregnant women should be included. The SARS-CoV-2 virus has been described as having a predilection for the ACE II receptor present in pneumocytes, enterocytes and at the placental. The placental condition could cause hypoperfusion and thrombosis; restriction on intrauterine growth and/or preterm birth. The most common symptoms in pregnant women with COVID-19 are fever, cough, muscle pain, dyspnoea and respiratory distress data. Diagnosis should be made by rt-PCR for SARS-CoV-2, in nasopharyngeal exudate and oropharyngeal. It is recommended that health workers caring for pregnant women strictly follow the recommended prevention measures. At present, there is no vaccine for this disease, however various drugs have been described that could be useful, taking into account the risk-benefit of each of these.


REFERENCES

  1. Rasmussen S, Smulian J, Lednicky J, Wen T, Jamieson D. Coronavirus disease 2019(COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020; 222: 415-426.

  2. López M, Gonce A, Meler E, Plaza A, Hernández S, Martínez PR et al. Coronavirus disease 2019 in pregnancy: A clinical management protocol and considerations for practice. Fetal Diagn Ther. 2020; 47: 519-528.

  3. Dashraath P, Wong J, Lim M, Lim L, Li S, Biswas A et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020; 222: 521-531.

  4. Ortiz E, Castañeda E, De La Torre A. Coronavirus (COVID-19) infection in pregnancy. Colomb, Medica. 2020, p. 1-7.

  5. Alfaraj S, Al-Tawfiq J, Memish Z. Middle east respiratory syndrome coronavirus infection during pregnancy: report of two cases & review of the literature. J Microbiol Immunol. 2019; 52: 501-503.

  6. Gao Q, Chen Y, Fang J. 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis. 2020; 21: 125-126.

  7. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the cytokine storm in COVID-19. J Infect. 2020; 80: 607-613.

  8. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020; 10: 102-108.

  9. Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020; 55: 10594-10598.

  10. Khan S, Jun L, Nawsherwan, Siddique R, Li Y, Han G et al. Association of COVID-19 with pregnancy outcomes in health-care workers and general women. Clin Microbiol Infect. 2020; 26: 788-790.

  11. Madjid M, Safavi-Naeini P, Solomon S, Vardeny O. Potential effects of coronaviruses on the cardiovascular system. JAMA Cardiol. 2020; 5: 831-832.

  12. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18: 1023-1026.

  13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844-847.

  14. Lippi G, Plebani M, Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020; 506: 145-148.

  15. Levi M, Scully M. How I treat disseminated intravascular coagulation. Blood Adv. 2018; 131: 845-854.

  16. Tang N, Bai H, Chen X, Gong J, Li D, Sun Z et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020; 18: 1094-1099.

  17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497-506.

  18. Taylor F, Toh C, Hoots K, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001; 86: 1327-1330.

  19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.

  20. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395: 809-815.

  21. Kong W, Agarwal P. Chest imaging appearance of COVID-19 infection. Radiol Cardiothorac Imaging. 2020; 2: 200028.

  22. Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020; 28: 1-2.

  23. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020; 14: 72-73.

  24. Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59: 252-256.

  25. Della GA, Rizzo R, Pilu G, Simonazzi G. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 2020; 223: 36-41.

  26. Tekbali A, Grünebaum A, Saraya A, McCullough L, Bornstein E, Chervenak F et al. Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in new york. Am J Obstet Gynecol. 2020; 223: 126-127.

  27. Chen S, Huang B, Luo DJ, Li X, Yang F, Zhao Y et al. Pregnancy with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases. Chin Med J. 2020; 49: 5-6.

  28. Robertson C, Lowther S, Birch T, Tan C, Sorhage F, Stockman L et al. SARS and pregnancy: a case report. Emerg Infect Dis. 2004; 10: 345-348.

  29. Khan S, Jun L, Nawsherwan, Siddique R, Li Y, Han G et al. Association of COVID-19 with pregnancy outcomes in health-care workers and general women. Clin Microbiol Infect. 2020; 26: 788-790.

  30. Omer S, Ali S, Babar Z. Preventive measures and management of COVID-19 in pregnancy. Drugs Ther Perspect. 2020; 36: 246-249.

  31. Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med. 2020; 18:1.

  32. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18: 1023-1026.

  33. Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L et al. Dexamethasone in hospitalized patients with COVID-19. Preliminary report. N Engl J Med. 2020: 2-20.

  34. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30: 269-271.

  35. Lacroix I, Bénévent J, Damase MC. Chloroquine and hydroxychloroquine during pregnancy: what do we know? Therapie. 2020; 75: 384-385.

  36. Grisolia G, Franchini M, Glingani C, Inglese F, Garuti M, Beccaria M et al. Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review. Am J Obstet Gynecol. 2020; 100174.

  37. Wu R, Wang L, Kuo H, Shannar A, Peter R, Chou P et al. An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep. 2020; 6: 56-70.




2020     |     www.medigraphic.com